Cargando…
Classification for Staging and Managing Patients with Biopolymer-induced Human Adjuvant Disease
Biopolymer-induced human adjuvant disease (BHAD) is a chronic clinical condition that requires surgical intervention, regardless of the presence of symptoms, to minimize the risk of functional, aesthetic, and systemic sequelae and the development of conditions simulating autoimmune disease. We propo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878701/ https://www.ncbi.nlm.nih.gov/pubmed/35233337 http://dx.doi.org/10.1097/GOX.0000000000004137 |